A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).
about
Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachClinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful?Guidelines on the investigation and management of antiphospholipid syndrome.The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism.Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review.The antiphospholipid syndrome: from pathophysiology to treatment.Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.Study about correlation of anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies with thromboangiitis obliterans.Invitation to a debate on the serological criteria that define the antiphospholipid syndrome.Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
P2860
Q36718482-2B02C75F-2E3A-47C5-AD68-6115311E9263Q37218750-6A5EAEA0-D75E-4936-A030-7713773B8F1DQ37982121-2BDA7BB0-8141-401F-9F9A-5C40782CB0A4Q38250865-3147A0B7-AB39-4247-B55D-3CD8DA8D9F45Q38596401-A8670AA5-EE06-411E-A4CF-B4DC07F4AE2FQ38873953-C3BDE7DF-BC80-412E-BAAD-2944AE601F1EQ41619784-994FAC2F-AF9C-4DBB-B135-D05A84A66491Q44125351-B3509C35-0AA7-4891-ACC7-A758F37CE38BQ48034591-6588094E-2526-41AC-A9B1-B28072B45737Q49091040-13B3BBE8-F8D6-44C8-8625-0B5155238D12Q49158813-BE6E2B6B-5B1D-4548-B712-4C857D079279
P2860
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A prospective study of anticar ...... l population (the HUNT study).
@en
type
label
A prospective study of anticar ...... l population (the HUNT study).
@en
prefLabel
A prospective study of anticar ...... l population (the HUNT study).
@en
P2093
P2860
P1476
A prospective study of anticar ...... al population (the HUNT study)
@en
P2093
Hammerstroem J
Rosendaal FR
P2860
P356
10.1111/J.1538-7836.2005.01691.X
P577
2006-01-01T00:00:00Z